Publications 2026

Bjørgo E, Ånensen N, Fagereng GL, Russnes HG, Smeland S, Taskén K, Helland Å (2026)
Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025
Acta Oncol, 65, 181-185
DOI 10.2340/1651-226X.2026.45168, PubMed 41778669

Frisell O, Aas E, Henkel PS, Fagereng GL, Taskén K, Hallersjö Hult E, Lindgren P, Steen Carlsson K (2026)
A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology
Acta Oncol, 65, 141-147
DOI 10.2340/1651-226X.2026.45088, PubMed 41711494

Henkel PS, Pedersen K, Taskén K, Hult EH, Gelderblom H, Fagereng GL, Landsverk HB, Aas E, PCM4EU consortium partners (2026)
Precision cancer medicine in Europe: a mixed-methods study on infrastructure for extended molecular diagnostics
J Cancer Res Clin Oncol, 152 (4)
DOI 10.1007/s00432-026-06468-y, PubMed 41927843

Martin Agudo M, Van der Pol H, Bratseth Stav G, Kringelbach T, Puco K, Flobak Å, Gelderblom H, Taskén K, Fagereng GL, Hovig E, PRIME-ROSE Consortium (2026)
'Crossing borders' in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine
Acta Oncol, 65, 159-163
DOI 10.2340/1651-226X.2026.45120, PubMed 41733536

Van der Pol H, Kringelbach T, Martin Agudo M, Bratseth Stav G, Fagereng GL, Fiocco M, Sørum Falk R, Homer V, Haj Mohammad S, Timmer H, Verlingue L, Helland Å, Rohrberg K, Lassen U, Halford S, Jalkanen K, Juslin T, Krebs MG, Oliveira J, Baltruskeviciene E, Ojamaa K, Taskén K, Gelderblom H (2026)
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project
Acta Oncol, 65, 1-8
DOI 10.2340/1651-226X.2026.44889, PubMed 41496458

Publications 2025

Henkel PS, Aas E, Russnes HG, Dyvik I, Fagereng GL, Helland Å, Røgenes H, Lien TG, Pedersen K (2025)
Microcosting Study of Genomic Profiling for Precision Cancer Medicine: Application from the National Infrastructure for Precision Diagnostics in Norway
J Mol Diagn, 27 (10), 945-953
DOI 10.1016/j.jmoldx.2025.06.006, PubMed 40712993

Publications 2024

Bjørgo E, Fagereng GL, Russnes HG, Smeland S, Taskén K, Helland Å (2024)
Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 - merging clinical research and standard healthcare
Acta Oncol, 63, 487-490
DOI 10.2340/1651-226X.2024.24954, PubMed 38910311

Fagereng GL, Morvik AM, Reinvik Ulimoen S, Ringerud AM, Dahlen Syversen I, Sagdahl E (2024)
The impact of level of documentation on the accessibility and affordability of new drugs in Norway
Front Pharmacol, 15, 1338541
DOI 10.3389/fphar.2024.1338541, PubMed 38420198

Helland Å, Steinskog ESS, Blix ES, Flobak Å, Brabrand S, Puco K, Niehusmann P, Meltzer S, Oppedal IA, Haug Å, Torkildsen CF, Randen U, Gilje B, Lønning PE, Gjertsen BT, Hovland R, Russnes HG, Fagereng GL, Smeland S, Tasken K (2024)
[Raising the quality of cancer treatment]
Tidsskr Nor Laegeforen, 144 (1)
DOI 10.4045/tidsskr.23.0740, PubMed 38258713

Puco K, Fagereng GL, Brabrand S, Niehusmann P, Støre Blix E, Samdal Steinskog ES, Haug Å, Fredvik Torkildsen C, Oppedal IA, Meltzer S, Flobak Å, Johansson KAM, Bjørge L, Hjortland GO, Dalhaug A, Lund JÅ, Gilje B, Grønlie Cameron M, Hovland R, Falk RS, Smeland S, Giercksky Russnes HE, Taskén K, Helland Å, InPreD Consortium, IMPRESS-Norway Consortium (2024)
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results
Acta Oncol, 63, 379-384
DOI 10.2340/1651-226X.2024.28322, PubMed 38779911

Taskén K, Haj Mohammad SF, Fagereng GL, Sørum Falk R, Helland Å, Barjesteh van Waalwijk van Doorn-Khosrovani S, Steen Carlsson K, Ryll B, Jalkanen K, Edsjö A, Russnes HG, Lassen U, Hallersjö Hult E, Lugowska I, Blay JY, Verlingue L, Abel E, Lowery MA, Krebs MG, Staal Rohrberg K, Ojamaa K, Oliveira J, Verheul HMW, Voest EE, Gelderblom H, PRIME-ROSE Consortium and the PCM4EU Consortium (2024)
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe
Acta Oncol, 63, 385-391
DOI 10.2340/1651-226X.2024.34791, PubMed 38779910

Publications 2022

Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D, Hjortland GO, Hovig E, Hovland R, Iversen AC, Janssen E et al. (2022)
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
J Transl Med, 20 (1), 225
DOI 10.1186/s12967-022-03432-5, PubMed 35568909

Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D, Hjortland GO, Hovig E, Hovland R, Iversen AC, Janssen E et al. (2022)
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
J Transl Med, 20 (1), 317
DOI 10.1186/s12967-022-03518-0, PubMed 35841045

Taskén K, Russnes HEG, Aas E, Bjørge L, Blix ES, CONNECT Public–Private Partnership Consortium, Enerly E, Fagereng GL, Flobak Å, Gilje B, Gjertsen BT, Guren TK, Heix J, Hovig E, Hovland R, InPreD-Norway and National Molecular Tumor Board Consortium, IMPRESS-Norway Consortium, Lønning PE, Meza-Zepeda LA, Mæhle PM, Nilsen HL, Thoresen SØ, Widerberg K, Smeland S, Helland Å (2022)
A national precision cancer medicine implementation initiative for Norway
Nat Med, 28 (5), 885-887
DOI 10.1038/s41591-022-01777-4, PubMed 35513529

Publications 2010

Hafte TT, Fagereng GL, Prydz K, Grøndahl F, Tveit H (2010)
Protein core-dependent glycosaminoglycan modification and glycosaminoglycan-dependent polarized sorting in epithelial Madin-Darby canine kidney cells
Glycobiology, 21 (4), 457-66
DOI 10.1093/glycob/cwq180, PubMed 21062785

Publications 2009

Tveit H, Akslen LK, Fagereng GL, Tranulis MA, Prydz K (2009)
A secretory Golgi bypass route to the apical surface domain of epithelial MDCK cells
Traffic, 10 (11), 1685-95
DOI 10.1111/j.1600-0854.2009.00984.x, PubMed 19765262